See All Slides - tctmd.com

Slides

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

Switzerland Presents: Cases Demonstrating TAVR Limitations

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Peter Wenaweser

October 31, 2017

Presentation TCT 2017

Case Comments: What Does Evidence-Based Medicine Say?

Presenter: Sergey A. Abugov, Alexey Protopopov, Daniel J. Blackman

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Case Comments: How Should We Treat This Patient?

Presenter: Sergey A. Abugov, Alexey Protopopov, Evgeny V. Merkulov

October 31, 2017

Presentation TCT 2017

Editorial Perspective: Long-term Valve Performance and Durability: The Next Frontier in Catheter-based Valve Technologies

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

Case #6 Introduction: 72-Year-Old Patient With NSTEMI, Ongoing Ischemia, and Incipient Pulmonary Edema With a Tight Left Main Lesion and Moderately Impaired LV Function

Presenter: Sergey A. Abugov, Alexey Protopopov, Nick Curzen

October 31, 2017

Presentation TCT 2017

Transforming Heart Valve Performance and Manufacturing (Foldax)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Steven J. Yakubov

October 31, 2017

Presentation TCT 2017

Reimbursement Models for Office Interventional Suites and Ambulatory Surgery Centers

Presenter: Jeffrey G. Carr, Bret N. Wiechmann

October 31, 2017

Advertisement

Slides

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Switzerland Presents: Cases Demonstrating TAVR Limitations

Case Comments: What Does Evidence-Based Medicine Say?

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Case Comments: How Should We Treat This Patient?

Editorial Perspective: Long-term Valve Performance and Durability: The Next Frontier in Catheter-based Valve Technologies

Case #6 Introduction: 72-Year-Old Patient With NSTEMI, Ongoing Ischemia, and Incipient Pulmonary Edema With a Tight Left Main Lesion and Moderately Impaired LV Function

Transforming Heart Valve Performance and Manufacturing (Foldax)

Reimbursement Models for Office Interventional Suites and Ambulatory Surgery Centers

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content